Our data reported here unveils FAM134B-BiP complex-mediated ER-phagy as a novel mechanism by which cancer cells prevail over hypoxia-induced proteotoxic stress and targeting ER-phagy machinery as a prospective therapeutic strategy to treat cancer. This evidence concerns the gene HSPA5 and cancer.